TP53BP1 and severe acute respiratory syndrome: Such opposing changes in lung gamma‐H2A.X and 53BP1 expression have been recently reported in response to a severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection (Gioia et al. 2023), supporting a common response elicited by IAV and SARS‐CoV‐2.